SCHEMBL7705538

SCHEMBL7705538

COCC(COC(C)=O)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 3/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PGR P06401 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
HTR1A P08908 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRM3 P20309 1/20 0.37
TBXA2R P21731 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA7 P36544 1/20 0.37
CHRNA4 P43681 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CHRNA10 Q9GZZ6 1/20 0.37
CHRNA9 Q9UGM1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25628009 0.93 TDP1 (0.45) TDP1ALDH1A1LMNAHSD17B10PGR
SCHEMBL10338761 0.86 PRKCA (0.43) TDP1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL1092940 0.84 TDP1 (0.48) TDP1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL12311562 0.82 ENPP2 (0.37) ALDH1A1ENPP2PRKCALPAR6LPAR1
SCHEMBL139623 0.82 ALDH1A1 (0.44) TDP1ALDH1A1LMNAHSD17B10TSHR
SCHEMBL14346944 0.80 MGAM (0.36) TDP1ALDH1A1LMNAENPP2PRKCA
SCHEMBL12672249 0.80 ENPP2 (0.36) ALDH1A1ENPP2PRKCALPAR6LPAR1
SCHEMBL28565968 0.80 ALOX15 (0.41) LMNACHRM2CHRM4HTR1ACHRM5
SCHEMBL14022057 0.79 MGAM (0.46) ENPP2PRKCALPAR6LPAR1LPAR4
SCHEMBL6751821 0.79 TSHR (0.57) TDP1ALDH1A1TSHRENPP2LPAR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115718406-A Photosensitive resin composition for forming resist, resin film, cured film, and semiconductor device 住友电木株式会社 2023-02-28 CN disclosed
US-20150056181-A1 NANOCARRIERS WITH MULTI-PHOTON RESPONSE ELEMENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-02-26 US disclosed
US-7718343-B2 Decomposable resin composition and pattern-forming material including the same FUJIFILM CORPORATION (JP) 2010-05-18 US disclosed
US-20090215979-A1 Process for the preparation of alkoxyamine functionalized polyethylene glycols NOVO NORDISK A/S (DK) 2009-08-27 US disclosed
US-20080070154-A1 DECOMPOSABLE RESIN COMPOSITION AND PATTERN-FORMING MATERIAL INCLUDING THE SAME FUJIFILM CORPORATION (JP) 2008-03-20 US disclosed
CN-1113102-C Antitumor preparation TRUOG PETER (CH) 2003-07-02 CN disclosed
EP-0807185-B9 ANTITUMOR PREPARATIONS CONTAINING A LIPOTEICHOIC ACID FROM STEPTOCOCCUS LUNAMED AG (CH) 2002-12-11 EP disclosed
EP-0807185-B1 ANTITUMOR PREPARATIONS CONTAINING A LIPOTEICHOIC ACID FROM STEPTOCOCCUS LUNAMED AG (CH) 2002-06-12 EP disclosed
US-6214978-B1 HAS LIPID ANCHOR, WHICH IS GALACTO-FURANOSYL-BETA-1-3-GLYCEROL WITH DIFFERENT FATTY ACIDS ESTERIFIED IN THE TWO ADJACENT HYDROXY GROUPS, AND HYDROPHILIC BACKBONE OF 10 GLYCEROPHOSPHATE UNITS ESTERIFIED WITH D-ALANINE TO 30% LUNAMED AG (CH) 2001-04-10 US disclosed
US-6114161-A Antitumor preparations LUNAMED AG (CH) 2000-09-05 US disclosed
CN-1173206-A Antitumor and anticholesterol preparations containing streptococcal lipoteichoic acid PETER TRUOG (CH) 1998-02-11 CN disclosed
EP-0807185-A1 ANTITUMOR AND ANTICHOLESTEROL PREPARATIONS CONTAINING A LIPOTEICHOIC ACID FROM STEPTOCOCCUS Truog, Peter, Dr. med. (CH) 1997-11-19 EP disclosed
WO-1996023896-A1 ANTITUMOR AND ANTICHOLESTEROL PREPARATIONS CONTAINING A LIPOTEICHOIC ACID FROM STEPTOCOCCUS TRUOG PETER (CH) 1996-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150056181-A1 NANOCARRIERS WITH MULTI-PHOTON RESPONSE ELEMENTS LRBA, PICALM, IPMK TDP1 476/4885ALDH1A1 4769/4885LMNA 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.